Eudragit NE30D Based Metformin/Gliclazide Extended Release Tablets: Formulation, Characterisation and in Vitro Release Studies

Chemical and Pharmaceutical Bulletin - Japan
doi 10.1248/cpb.50.1495
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

Formulation and in Vitro Evaluation of Theophylline-Eudragit® Sustained-Release Tablets

Revista Brasileira de Ciências Farmacêuticas
2005English

Formulation and Evaluation of Metformin Hydrochloride Sustained-Release Oral Matrix Tablets

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Formulation and Evaluation of Extended Release Tablets of Tramadol Hydrochloride

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY
2013English

The Development of Eudragit® NM-Based Controlled-Release Matrix Tablets

Medicina
Medicine
2012English

Solid Stability Testing of Ibuprofen - Eudragit Respm Sustained Release Tablets

Bulletin of Pharmaceutical Sciences
PharmacologyPharmaceutical Science
1993English

Formulation and Evaluation of Cephalexin Extended Release Matrix Tablets Using 32 Factorial Design

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2011English

Prediction of in Vitro Drug Release Mechanisms From Extended Release Matrix Tablets Using SSR/R2 Technique

Trends in Applied Sciences Research
2011English

Design and in Vitro Evaluation of Eudragit-Based Extended Release Diltiazem Microspheres for Once- And Twice-Daily Administration: The Effect of Coating on Drug Release Behavior

Turkish Journal of Pharmaceutical Sciences
Molecular MedicinePharmaceutical Science
2019English

Development of in Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation

AAPS Journal
Pharmaceutical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy